Deals

Catasys Issues $1.72M in Common Stock

By |

Catasys Inc. (CATS) announced that it has raised $1,719,000 in a Common Stock transaction with investors including Socius Partners. The health management specialist's common stock was sold at $0.10 per share, an approximate 31% discount to the market price ($0.15) ofCATS at deal announcement. A series of 17,190,000 60-Month Warrants with an exercise price of $0.10 per share (31.03% discount) was issued to the investors in this transaction. This transaction was completed without an agent. Issuer counsel was Mintz Levin. The transaction closed on Sept.

Deals

China Cord Blood in $50M Convertible Deal

By |

China Cord Blood Corp. (CO) announced that it has raised $50 million in a Convertible Senior

Unsecured Notes transaction with investor Golden Meditech Holdings Ltd. The fixed conversion price of the Convertible Senior Unsecured Notes is $2.838 per share, an approximate 6.29% premium to the market price ($2.67) of CO at Sept. 18 deal announcement. Cowen and Company acted as the Financial Advisor. Issuer counsel was Loeb & Loeb, and investor counsel was Kramer Levin Naftalis & Frankel.

Deals

Pioneer Pharma Buys into Novabay PIPE

By |

Novabay Pharmaceuticals (NBY) announced that it has raised $1 million in a Unit (Common Stock and Warrants) transaction with investor Pioneer Pharma (Singapore). The common stock was sold at $1.25 per share, an approximate 9% discount to the market price ($1.38) of NBY at deal announcement. A series of 800,000 12-Month Warrants with an exercise price of $1.50 per share (8.7% premium) was issued to the investors in this transaction. The Placement Agent was not disclosed. The transaction closed on Sept.

Deals

Aegis Capital Places Neuralstem Shares

By |

Neuralstem (CUR) announced that it has raised $7 million in a Registered Direct transaction. The common stock was sold at $1.00 per share, an approximate 28% discount to the market price ($1.38) of CUR at deal announcement. Aegis Capital Corporation acted as the exclusive agent on the transaction. The transaction is expected to close on Sept. 19, 2012.